Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

79.4K
Overview
79.4K
CRISPR01:59

CRISPR

57.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

1.5K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.5K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

15.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.9K
CRISPR and crRNAs02:53

CRISPR and crRNAs

18.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.6K
Gene Therapy00:59

Gene Therapy

27.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On My Oath.

Southern medical journal·2023
Same author

Roles of Environmental Services Workers' Wages and Status in Patient Safety.

AMA journal of ethics·2022
Same author

Safer health care environments by design.

Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Management·2019
Same author

AORN Surgical Conference & Expo 2014 speaker interviews.

AORN journal·2013
Same author

Termination of life support after severe child abuse: the role of a guardian ad litem.

Pediatrics·2004
Same journal

What Makes a Good Physician? Asclepius and the Rhetoric of AI.

AMA journal of ethics·2025
Same journal

Response to "Response to 'Is the UDN N-of-1 Enterprise Ethically Justifiable?'".

AMA journal of ethics·2025
Same journal

Patient Voices on Diagnostic Research.

AMA journal of ethics·2025
Same journal

Response to "Is the UDN N-of-1 Enterprise Ethically Justifiable?"

AMA journal of ethics·2025
Same journal

Great Lakes Eutrophication and Respiratory Health Harms.

AMA journal of ethics·2025
Same journal

Lessons for Responsible Geroscience From the History of Longevity.

AMA journal of ethics·2025
See all related articles

Related Experiment Video

Updated: Jan 1, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.3K

How Should Gene Editing Be Managed by Risk Managers?

David Sine1

  • 1A certified professional health care risk manager and a former federal executive with experience in multiple disciplines, including enterprise risk management, organizational ethics, high reliability, and patient safety.

AMA Journal of Ethics
|December 27, 2019
PubMed
Summary
This summary is machine-generated.

Gene editing technology presents unique risks for healthcare organizations. Traditional risk management strategies are essential due to limited claims data for informed decision-making on loss control and mitigation.

More Related Videos

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

35.3K
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
08:20

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

4.5K

Related Experiment Videos

Last Updated: Jan 1, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.3K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

35.3K
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
08:20

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

4.5K

Area of Science:

  • Biotechnology and Healthcare Management

Background:

  • Gene editing is an emerging technology with significant implications for healthcare.
  • Limited historical claims data complicates risk assessment for novel gene editing applications.

Purpose of the Study:

  • To explore the challenges gene editing poses to healthcare risk managers and underwriters.
  • To evaluate the applicability of traditional risk management tools in the context of gene editing.

Main Methods:

  • Analysis of gene editing technology from the perspective of risk management.
  • Review of current risk mitigation strategies and their limitations.

Main Results:

  • Existing claims data is insufficient for robust risk assessment in gene editing.
  • Traditional risk management frameworks offer a foundational approach to managing uncertainties.

Conclusions:

  • Healthcare organizations must adapt traditional risk management tools to address gene editing risks.
  • Further research and data collection are needed to refine risk mitigation strategies for gene editing.